Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Apr;44(1):41-50.
doi: 10.1177/08897077231165625. Epub 2023 May 3.

"I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment

Jessica J Wyse  1   2 , Travis I Lovejoy  1   2   3 , Adam J Gordon  4   5 , Katherine Mackey  1   6 , Anders Herreid-O'Neill  7 , Benjamin J Morasco  1   3
Affiliations

"I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment

Jessica J Wyse et al. Subst Abus. 2023 Jan-Apr.

Erratum in

Abstract

Background: Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are also associated with improved clinical outcomes. Despite this, patients often express desires to discontinue treatment and some view taper as treatment success. Little is known about the beliefs and medication perspectives of patients engaged in long-term buprenorphine treatment that may underlie motivations to discontinue.

Methods: This study was conducted at the VA Portland Health Care System (2019-2020). Qualitative interviews were conducted with participants prescribed buprenorphine for ≥2 years. Coding and analysis were guided by directed qualitative content analysis.

Results: Fourteen patients engaged in office-based buprenorphine treatment completed interviews. While patients expressed strong enthusiasm for buprenorphine as a medication, the majority expressed the desire to discontinue, including patients actively tapering. Motivations to discontinue fell into 4 categories. First, patients were troubled by perceived side effects of the medication, including effects on sleep, emotion, and memory. Second, patients expressed unhappiness with being "dependent" on buprenorphine, framed in opposition to personal strength/independence. Third, patients expressed stigmatized beliefs about buprenorphine, describing it as "illicit," and associated with past drug use. Finally, patients expressed fears about buprenorphine unknowns, including potential long-term health effects and interactions with medications required for surgery.

Conclusions: Despite recognizing benefits, many patients engaged in long-term buprenorphine treatment express a desire to discontinue. Findings from this study may help clinicians anticipate patient concerns and can be used to inform shared decision-making conversations regarding buprenorphine treatment duration.

Keywords: buprenorphine; opioid-related disorders; veterans.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Authors have no conflicts of interest to report.

References

    1. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2). - PMC - PubMed
    1. Department of Veterans Affairs, Department of Defense. VA/DOD Clinical Practice Guideline: Management of Substance Use Disorder (SUD) 2021. Accessed May 24, 2022. https://www.healthquality.va.gov/guidelines/MH/sud/
    1. Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145. - PMC - PubMed
    1. National Academies of Sciences E and Medicine. Medications for Opioid Use Disorder Save Lives. National Academies Press; 2019. - PubMed
    1. Samples H, Williams AR, Crystal S, Olfson M. Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid: The impact of longer treatment on health care outcomes for opioid use disorder within a key population of Medicaid enrollees. Health Aff (Millwood). 2020;39(5):747–755. - PMC - PubMed

Publication types